Half-year report · HY
7716.TEDINET S100YULE
Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥47.2bn | 2026-01-01 → 2026-06-30 | Cons. | Net sales |
| Revenue | ¥81.2bn | 2025-01-01 → 2025-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥39.2bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2026-01-01 → 2026-06-30 | Cons. | Operating income |
| Operating income | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Ordinary income | ¥11.6bn | 2026-01-01 → 2026-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.9bn | 2025-01-01 → 2025-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥11.5bn | 2026-01-01 → 2026-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥7.0bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.4bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.1bn | 2026-01-01 → 2026-06-30 | Cons. | Profit loss |
| Net income | ¥3.5bn | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Total assets | ¥174.6bn | at 2026-06-30 | Cons. | Assets |
| Total assets | ¥160.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥153.8bn | at 2025-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥52.5bn | at 2026-06-30 | Cons. | Liabilities |
| Total liabilities | ¥46.1bn | at 2025-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥122.0bn | at 2026-06-30 | Cons. | Net assets |
| Net assets / equity | ¥114.1bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥117.3bn | at 2025-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥56.4bn | at 2026-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥61.3bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥40.4bn | at 2026-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥32.7bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥35.2bn | at 2024-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.6bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥16.6bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥7.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥19.0bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.7bn | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥4.7bn | 2026-01-01 → 2026-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥679m | 2025-01-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥2.6bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥98.07 | 2026-01-01 → 2026-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-28.7 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.84 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥97.72 | 2026-01-01 → 2026-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.7 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 69.6% | at 2026-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.0% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.0% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 40
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | revenue intersegment | 2026-01-01 → 2026-06-30 | −¥443m |
| Reconciling Itemsreconciling | segment profit | 2026-01-01 → 2026-06-30 | −¥2.2bn |
| DCI Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥12.2bn |
| DCI Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥674m |
| Dental Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥27.4bn |
| Dental Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥27.0bn |
| Dental Productsreportable segment | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| Dental Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥9.0bn |
| Industrial Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥4.2bn |
| Industrial Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.1bn |
| Surgical Productsreportable segment | revenue | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | revenue external | 2026-01-01 → 2026-06-30 | ¥3.9bn |
| Surgical Productsreportable segment | segment profit | 2026-01-01 → 2026-06-30 | ¥1.5bn |
| —segment total | revenue | 2026-01-01 → 2026-06-30 | ¥47.7bn |
| —segment total | revenue external | 2026-01-01 → 2026-06-30 | ¥47.2bn |
| —segment total | revenue intersegment | 2026-01-01 → 2026-06-30 | ¥443m |
| —segment total | segment profit | 2026-01-01 → 2026-06-30 | ¥12.3bn |
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥176m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.0bn |
| DCI Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥9.8bn |
| DCI Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥66m |
| Dental Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥23.7bn |
| Dental Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥23.5bn |
| Dental Productsreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| Dental Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥8.0bn |
| Industrial Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥3.3bn |
| Industrial Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥306m |
| Surgical Productsreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥2.5bn |
| Surgical Productsreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥1.2bn |
| —segment total | revenue | 2025-01-01 → 2025-06-30 | ¥39.4bn |
| —segment total | revenue external | 2025-01-01 → 2025-06-30 | ¥39.2bn |
| —segment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥176m |
| —segment total | segment profit | 2025-01-01 → 2025-06-30 | ¥9.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)須 山 誠 一 郎 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)飯 田 圭 一 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 39189728000 | JPY |
| Net sales (5-year summary) | InterimDuration | 47234964000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 81179143000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 6930322000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 11577319000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 16933969000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 3510366000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 8144522000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -2398213000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 304387000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 10192772000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -77106000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 117297546000 | JPY |
| Net assets (5-year summary) | InterimInstant | 122009771000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 114074441000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 153767488000 | JPY |
| Total assets (5-year summary) | InterimInstant | 174551385000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 160155463000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 41.84 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 98.07 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -28.70 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | 41.70 | |
| Diluted earnings per share (5-year summary) | InterimDuration | 97.72 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.760 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.696 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.710 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 7578364000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 7620752000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 16649420000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -6439803000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -18969432000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -8682539000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -2559014000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 4741131000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 679155000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 32650870000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 40448681000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 45964061000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 92218200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 92218200 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 92218200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 92218200 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 4530000000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.0545 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |